日前，美国生物制药公司吉利德公布Lenacapavir（来那卡帕韦）预防 HIV 的临床试验结果，显示出100%的有效性。 最新公布的结果是一项名为PURPOSE 1的III ...

2025-01-04 08:20发布于上海观察者网官方账号 （文/王力 编辑/徐喆）1月2日，国家药品监督管理局发布消息，吉利德科学的Sunlenca®（Lenacapavir，来那帕韦 ...

（文/王力 编辑/徐喆）1月2日，国家药品监督管理局发布消息，吉利德科学的Sunlenca®（Lenacapavir，来那帕韦钠注射液及片剂）正式获批上市，为艾滋 ...

Lenacapavir has shown high efficacy in managing multidrug-resistant cases, offering hope to patients with limited alternatives. A significant breakthrough in treating the Human Immunodeficiency ...

HIV防控迎来革命性突破，长效注射药物lenacapavir预防感染效果接近100%。 几十年的抗争让HIV的治疗取得了长足进步，但每年仍有超过一百万人感染。

A significant breakthrough in treating the Human Immunodeficiency Virus came recently with the US Federal Drug Administration approving lenacapavir, a new prototype medication. It uses a unique ...

ATLANTA - Lenacapavir, a new injectable drug for HIV prevention, is being hailed by Emory University medical experts as a breakthrough in the fight against the virus. The drug offers a long-acting ...

Lenacapavir requires just two injections a year and has shown remarkable success in trials. But it currently costs each patient more than $40,000 a year.

Due to its innovative mechanism and extended dosing schedule, Lenacapavir has been described as a pathbreaking advancement in HIV care and is being heralded as an early vaccine-like innovation in ...

Recent research has focused on innovative treatment options, particularly the development of new classes of antiretroviral drugs, such as lenacapavir, which is a first-in-class capsid inhibitor.